What's in EvergreenHealth's pipeline?

EvergreenHealth has 3 drugs in our index: 3 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with EvergreenHealth's portfolio?

Top competitors by shared drug class: Croma-Pharma GmbH, Helse Nord-Trøndelag HF, NICHD Pelvic Floor Disorders Network, Universidad Autonoma de Nuevo Leon, University of Calgary.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/evergreenhealth.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

EvergreenHealth — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

EvergreenHealth pipeline: 3 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Botulinum toxin A 100u	Botulinum toxin A 100u	marketed
Botulinum toxin A 150u	Botulinum toxin A 150u	marketed	Neurotoxin; Acetylcholine release inhibitor	SNARE proteins (specifically SNAP-25)	Neurology; Dermatology; Aesthetics
Botulinum toxin A 50u	Botulinum toxin A 50u	marketed	Neurotoxin; Acetylcholine release inhibitor	SNAP-25 (synaptosome-associated protein of 25 kDa)	Neurology; Dermatology; Aesthetics

Therapeutic area mix

Neurology; Dermatology; Aesthetics · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Croma-Pharma GmbH · 1 shared drug class
Helse Nord-Trøndelag HF · 1 shared drug class
NICHD Pelvic Floor Disorders Network · 1 shared drug class
Universidad Autonoma de Nuevo Leon · 1 shared drug class
University of Calgary · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for EvergreenHealth:

Cite this brief

Drug Landscape (2026). EvergreenHealth — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/evergreenhealth. Accessed 2026-05-16.